Anna Jerzak vel Dobosz

What are the current outcomes of advanced gastrointestinal stromal tumors: who are the long-term survivors treated initially with imatinib?

P. Rutkowski, M. Debiec‐Rychter, J. Siedlecki, 2013, Medical Oncology.

Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.

P. Nyckowski, P. Rutkowski, M. Debiec‐Rychter, 2007, Medical science monitor : international medical journal of experimental and clinical research.

KIT codon 558 insertions in gastrointestinal stromal tumors. Analysis of 17 rare KIT mutants.

E. Wardelmann, R. Sciot, S. Steigen, 2008, Human pathology.